Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? - PubMed (original) (raw)
Review
Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?
G-T Ho et al. Gut. 2003 May.
Abstract
The interface between luminal contents and intestinal epithelium constitutes the largest area of interaction between the host and the environment. There is now strong evidence that the gene product of the multidrug resistant pump (MDR) plays a critical role in host-bacterial interactions in the gastrointestinal tract and maintenance of intestinal homeostasis. This review highlights the efflux mechanism in the intestinal epithelium which is mediated by the multidrug resistant pump, also known as P-glycoprotein 170. Current studies promise to provide further insights into the contribution of the MDR1 gene in the pathogenesis of inflammatory and malignant disorders of the gastrointestinal tract.
Figures
Figure 1
Two dimensional hypothetical structure of the P-glycoprotein 170 pump.
Figure 2
Three dimensional hypothetical structure of P-glycoprotein viewed from above (A) and below (B). NBD, nuclear binding domain; P, pore; TMD, transmembrane domain.
Similar articles
- Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis.
Annese V, Valvano MR, Palmieri O, Latiano A, Bossa F, Andriulli A. Annese V, et al. World J Gastroenterol. 2006 Jun 21;12(23):3636-44. doi: 10.3748/wjg.v12.i23.3636. World J Gastroenterol. 2006. PMID: 16773678 Free PMC article. Review. - Multidrug resistance in the chronic lymphoproliferative disorders.
Drain S, Catherwood MA, Alexander HD. Drain S, et al. Leuk Lymphoma. 2010 Oct;51(10):1793-804. doi: 10.3109/10428194.2010.500434. Leuk Lymphoma. 2010. PMID: 20615085 Review. - The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer.
Baker EK, El-Osta A. Baker EK, et al. Exp Cell Res. 2003 Nov 1;290(2):177-94. doi: 10.1016/s0014-4827(03)00342-2. Exp Cell Res. 2003. PMID: 14567978 Review. - Genetically determined differences in P-glycoprotein function: implications for disease risk.
Fromm MF. Fromm MF. Toxicology. 2002 Dec 27;181-182:299-303. doi: 10.1016/s0300-483x(02)00297-4. Toxicology. 2002. PMID: 12505329 Review. - Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells.
Chen XP, Wang Q, Guan J, Huang ZY, Zhang WG, Zhang BX. Chen XP, et al. World J Gastroenterol. 2006 Jun 7;12(21):3332-7. doi: 10.3748/wjg.v12.i21.3332. World J Gastroenterol. 2006. PMID: 16733848 Free PMC article.
Cited by
- Natural Products as a Tool to Modulate the Activity and Expression of Multidrug Resistance Proteins of Intestinal Barrier.
Martins-Gomes C, Silva AM. Martins-Gomes C, et al. J Xenobiot. 2023 Mar 25;13(2):172-192. doi: 10.3390/jox13020014. J Xenobiot. 2023. PMID: 37092502 Free PMC article. Review. - Pathogenesis of primary sclerosing cholangitis.
Pollheimer MJ, Halilbasic E, Fickert P, Trauner M. Pollheimer MJ, et al. Best Pract Res Clin Gastroenterol. 2011 Dec;25(6):727-39. doi: 10.1016/j.bpg.2011.10.009. Best Pract Res Clin Gastroenterol. 2011. PMID: 22117638 Free PMC article. Review. - Role of nuclear receptor PXR in immune cells and inflammatory diseases.
Sun L, Sun Z, Wang Q, Zhang Y, Jia Z. Sun L, et al. Front Immunol. 2022 Sep 2;13:969399. doi: 10.3389/fimmu.2022.969399. eCollection 2022. Front Immunol. 2022. PMID: 36119030 Free PMC article. Review. - Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum.
Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, Liao X, Waldron L, Hoshida Y, Huttenhower C, Chan AT, Giovannucci E, Fuchs C, Ogino S. Yamauchi M, et al. Gut. 2012 Jun;61(6):847-54. doi: 10.1136/gutjnl-2011-300865. Epub 2012 Mar 17. Gut. 2012. PMID: 22427238 Free PMC article. - The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen.
Weitschies W, Bernsdorf A, Giessmann T, Zschiesche M, Modess C, Hartmann V, Mrazek C, Wegner D, Nagel S, Siegmund W. Weitschies W, et al. Pharm Res. 2005 May;22(5):728-35. doi: 10.1007/s11095-005-2588-5. Epub 2005 May 17. Pharm Res. 2005. PMID: 15906167 Clinical Trial.
References
- Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976;455:152–62. - PubMed
- Hsu SI, Lothstein L, Horwitz SB. Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes. J Biol Chem 1989;264:12053–62. - PubMed
- Chen CJ, Chin JE, Ueda K, et al. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986;47:381–9. - PubMed
- Ueda K, Clark DP, Chen CJ, et al. The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J Biol Chem 1987;262:505–8. - PubMed
- Fardel O, Payen L, Courtois A, et al. Regulation of biliary drug efflux pump expression by hormones and xenobiotics. Toxicology 2001;167:37–46. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources